Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 56.69B | 55.85B | 52.10B | 48.04B | 44.03B | 43.13B |
Gross Profit | 24.74B | 24.49B | 22.68B | 20.61B | 36.04B | 30.07B |
EBITDA | 21.49B | 21.54B | 19.52B | 19.82B | 19.00B | 18.01B |
Net Income | 5.71B | 5.55B | 5.03B | 4.09B | 6.24B | 4.77B |
Balance Sheet | ||||||
Total Assets | 126.61B | 124.94B | 120.74B | 119.12B | 115.74B | 108.74B |
Cash, Cash Equivalents and Short-Term Investments | 8.19B | 6.69B | 4.36B | 2.27B | 6.45B | 5.76B |
Total Debt | 20.56B | 20.75B | 18.74B | 19.30B | 16.93B | 13.24B |
Total Liabilities | 58.46B | 55.14B | 51.11B | 50.67B | 45.66B | 39.18B |
Stockholders Equity | 68.07B | 69.73B | 69.57B | 68.40B | 70.01B | 69.56B |
Cash Flow | ||||||
Free Cash Flow | 10.30B | 10.55B | 9.97B | 9.05B | 8.78B | 11.05B |
Operating Cash Flow | 20.04B | 19.88B | 18.79B | 18.94B | 18.07B | 19.34B |
Investing Cash Flow | -9.39B | -8.91B | -7.85B | -14.20B | -8.13B | -6.41B |
Financing Cash Flow | -9.22B | -8.63B | -8.85B | -8.91B | -9.26B | -10.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $16.98B | 11.52 | 16.28% | 5.89% | -5.14% | -7.47% | |
79 Outperform | $9.83B | 15.98 | 13.18% | 0.42% | -6.63% | 2.46% | |
78 Outperform | $18.92B | 18.65 | 7.95% | 1.95% | -5.69% | -0.05% | |
74 Outperform | $8.99B | 10.21 | 11.08% | 4.37% | -4.13% | 4.96% | |
61 Neutral | $41.01B | -0.64 | -14.21% | 3.80% | 2.39% | -73.52% | |
59 Neutral | $30.24B | ― | -0.55% | 4.50% | -2.29% | -182.68% | |
57 Neutral | $26.30B | 9.21 | -7.17% | 4.74% | 0.89% | -494.16% |